For more information, availability and pricing options for sponsorship/exhibition opportunities at the event, please contact Jon Liong at email@example.com.
QuintilesIMS (NYSE:Q) is a leading integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles and IMS Health, QuintilesIMS’s approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes and enhanced clinical trial outsourcing through treatment innovations, care provision and access can leverage QuintilesIMS’s broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS provides solutions that span clinical to commercial bringing clients a unique opportunity to realize the full potential of innovations and advance healthcare outcomes.
As a global leader in protecting individual patient privacy, QuintilesIMS uses healthcare data to deliver critical, real-world disease and treatment insights. Through a wide variety of privacy-enhancing technologies and safeguards, QuintilesIMS protects individual privacy while managing information to drive healthcare forward. These insights and execution capabilities help biotech, medical device, and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders in the development and approval of new therapies, identify unmet treatment needs and understand the safety, effectiveness and value of pharmaceutical products in improving overall health outcomes. To learn more, visit www.QuintilesIMS.com.
AMICULUM® is different from other global healthcare communications agencies. Development of a significant presence in China is fundamental to our business plan and we have had a team based in Shanghai since 2008. The company remains an independent business with its founders actively involved in leading the development of the full range of AMICULUM’s services throughout Asia.
Supported by our colleagues in Singapore, New Zealand, UAE, Switzerland, UK and USA we are able to deliver world-class medical communications, healthcare learning and consulting services to leading pharmaceutical companies in China. We also have significant expertise in the planning and delivery of regional and global programmes.
AMICULUM Asia provides our clients with the full range of technical expertise and experience which resides in our global agency brands:
- Mudskipper and 7.4 (healthcare communications)
- Comradis (rare diseases)
- Delta Kn (online learning and virtual events)
- Evida Medical and AMICULUM Consulting (clinical and commercial advisory services)
- AMICULUM Digital develops bespoke digital communications platforms and is a Veeva CLM partner
To learn more about AMICULUM, please visit our stand during the China Medical Affairs Summit. We will be delighted to meet you!
Fountain Medical Development
Fountain Medical Development Ltd. is a contract research organization (CRO) dedicated to offering a full range of ICH GCP compliant clinical research services for multinational clients conducting clinical research in China and United States, Europe, Japan, Australia, India, Philippines, Taiwan and other countries & regions including Regulatory Affairs, Phase I-IV clinical trials, Data Management and Biostatistics, Project Management, Medical Writing, Medical Translation, Safety Handling, Consulting and Pharmacoeconomic studies. The FMD management team has decades of combined experience working with the world’s leading CROs and drug developers. Our extensive global experience in multiple therapeutic areas is unmatched by other local CROs, and our lower operational cost allows us to pass significant savings on to our clients. Fountain has hands-on clinical trial experiences in mainland of China, Hong Kong, Taiwan, Korea, Japan, Armenia and the US, and has completed more than 200 clinical trial projects, we have been in good partnership with more than 300 sites in Asia and we have enrolled more than 80000 patients in clinical trials. Fountain’s success includes the excellent team, the strategic capability and undertaking pivotal international studies. Fountain is your trustworthy CRO Choice.
As a provider of cloud-based solutions in life sciences, Taimei Medical Technology has developed end-to-end integrated clinical trial and pharmacovigilance systems, from AIMS (Clinical Trial Management System, CTMS), eBalance® (Interactive Web-based Response System, IWRS), eReport®（Electronic Patient Report Outcomes, ePRO), eArchives® (Electronic Trial Master File, eTMF), to eSafety (Pharmacovigilance System, PVS), eCollege (Training Management System, TMS) and MIRS (Medical Image Reading System). To cope with the industry environments and client needs, Taimei Medical Technology further provide well-rounded solutions to clinical trial informationization, trial master files and pharmacovigilance based on Taimei core products, helping clients to optimize clinical trial and pharmacovigilance operation process, cost and efficiency. To date, Taimei Medical Technology has gained industry recognition through established collaborations with nearly 100 biopharma companies and CROs
Purple Clinic was founded in 2013, aims to build a Digital Medical Service platform for medical partners based on the mobile WeChat. According to the individual needs of partners, provide targeted solutions for medical enterprises to develop tailored of doctor education and patient education, and achieve win-win cooperation with partners. The service team is composed of Peking Union Medical College Hospital, apple, China, HUAWEI and other professional medical background and senior Internet product R & D innovation elite.
For pharmaceutical companies launching new drugs, finding out who to talk to has always been the number one priority. But the network of influencers has widened exponentially from the old model of “the top 100 doctors”. It now includes everyone from patient groups to charities, pharmacists to hospital managers.
Using a research-analyse-profile model, Thecosystems® let you see not just who are the most influential stakeholders in a particular disease, but also who else they are connected to and through which channels. Thecosystems is the brainchild of MMRG, a specialist stakeholder research consultancy. Launched in 1981, MMRG serves the needs of the global pharmaceutical industry, with many of the world's biopharmaceutical companies on its roster of clients. Our multidisciplinary team includes physicians, pharmacists, project managers and software specialists.
Established in 2011，Xingshulin Information Technology (Beijing) Co., Ltd. is one of the earliest explorers in the mobile medical field in China, and the largest mobile Internet company serving physicians in China, dedicated to developing mobile tools for medical professionals, aiming at promoting the professional capability and service efficiency of physicians. The users of the major products of the company (“Medical Pocket” and “Dossier”) include 30% of Chinese physicians, and more than 920 thousand registered physicians and medical students. The all-round mobile Internet services of the company cover case-history cloud service, project coordination among departments, physician brand and medical data.
The philosophy of the enterprise: serving millions of Chinese physicians, providing them with mobile Internet solutions, helping them to enhance efficiency, improve quality and increase output in their medical services to patients and in other daily work.